The Molecular and Cellular Basis of Tumor Rejection After Vaccination With Mammary Adenocarcinoma Cells Transduced With the MHC Class II Transactivator CIITA

被引：0
|
作者：
Lorenzo Mortara
Paola Castellani
Raffaella Meazza
Giovanna Tosi
Andrea De Lerma Barbaro
Francesco A Procopio
Luciano Zardi
Silvano Ferrini
Roberto S Accolla
机构：
[1] University of Insubria,Department of Clinical and Biological Sciences, School of Medicine
[2] Istituto Nazionale per la Ricerca sul Cancro,Laboratory of Cellular Biology
[3] Istituto Nazionale per la Ricerca sul Cancro,Laboratory of Immunopharmacology
[4] Advanced Biotechnology Center,Philogen
来源：
Retrovirology | / 2卷
关键词：
ELISPOT Assay; Vaccination Protocol; Massive Necrosis; Mammary Adenocarcinoma Cell; Syngeneic Recipient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA
    Mortara, Lorenzo
    Castellani, Paola
    Meazza, Raffaella
    Tosi, Giovanna
    Barbaro, Andrea De Lerma
    Procopio, Francesco A.
    Zardi, Luciano
    Ferrini, Silvano
    Accolla, Roberto S.
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [2] A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator ClITA
    Mortara, L
    Castellani, P
    Meazza, R
    Tosi, G
    Barbaro, ADL
    Procopio, FA
    Zardi, L
    Ferrini, S
    Accolla, RS
    TISSUE ANTIGENS, 2005, 66 (05): : 343 - 343
  • [3] Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells
    Meazza, R
    Comes, A
    Orengo, AM
    Ferrini, S
    Accolla, RS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (05) : 1183 - 1192
  • [4] Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
    Celesti, Fabrizio
    Gatta, Andrea
    Shallak, Mariam
    Chiaravalli, Anna Maria
    Cerati, Michele
    Sessa, Fausto
    Accolla, Roberto S.
    Forlani, Greta
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)
    Takamura, Y
    Ikeda, H
    Kanaseki, T
    Toyota, M
    Tokino, T
    Imai, K
    Houkin, K
    Sato, N
    GLIA, 2004, 45 (04) : 392 - 405
  • [6] The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney
    Sims, TN
    Afrouzian, M
    Urmson, J
    Zhu, LF
    Halloran, PF
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (03) : 211 - 221
  • [7] Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells
    Liu, AC
    Takahashi, M
    Toba, K
    Zheng, ZY
    Hashimoto, S
    Nikkuni, K
    Furukawa, T
    Koike, T
    Aizawa, Y
    HEMATOLOGICAL ONCOLOGY, 1999, 17 (04) : 149 - 160
  • [8] Transcriptional regulation of MHC class II transactivator, CIITA in human dendritic cells
    Wu, J
    Wright, G
    Zhong, B
    Acker, SA
    Piskurich, JF
    Ting, JPY
    Wei, S
    Wright, KL
    FASEB JOURNAL, 2003, 17 (07): : C295 - C295
  • [9] Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA
    Meazza, R
    Comes, A
    Barbaro, AD
    Tosi, G
    Ferrini, S
    Accolla, R
    TISSUE ANTIGENS, 2002, 59 : 5 - 5
  • [10] Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA
    Comes, A
    Meazza, R
    Tosi, G
    Barbaro, AD
    Ferrini, S
    Accolla, RS
    FASEB JOURNAL, 2000, 14 (06): : A1001 - A1001
12345